These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27368347)

  • 1. Blocking of CD1d Decreases Trypanosoma cruzi-Induced Activation of CD4-CD8- T Cells and Modulates the Inflammatory Response in Patients With Chagas Heart Disease.
    Passos LS; Villani FN; Magalhães LM; Gollob KJ; Antonelli LR; Nunes MC; Dutra WO
    J Infect Dis; 2016 Sep; 214(6):935-44. PubMed ID: 27368347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct CD4
    Passos LSA; Koh CC; Magalhães LMD; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2021; 12():761795. PubMed ID: 34868005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific activation of CD4
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
    Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking activation of CD4
    Neves EGA; Koh CC; Lucinda PPD; Souza-Silva TG; Medeiros NI; Pantaleão A; Mutarelli A; Gomes JAS; Silva SA; Gollob KJ; Nunes MDCP; Dutra WO
    Clin Immunol; 2023 Jun; 251():109331. PubMed ID: 37088297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Human CD11b
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2018; 9():3015. PubMed ID: 30662439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease.
    Villani FN; Rocha MO; Nunes Mdo C; Antonelli LR; Magalhães LM; dos Santos JS; Gollob KJ; Dutra WO
    Infect Immun; 2010 Oct; 78(10):4421-30. PubMed ID: 20696836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
    Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic
    Fonseca R; Salgado RM; Borges da Silva H; do Nascimento RS; D'Império-Lima MR; Alvarez JM
    Front Immunol; 2018; 9():997. PubMed ID: 29867974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.
    Chaves AT; de Assis Silva Gomes Estanislau J; Fiuza JA; Carvalho AT; Ferreira KS; Fares RC; Guimarães PH; de Souza Fagundes EM; Morato MJ; Fujiwara RT; da Costa Rocha MO; Correa-Oliveira R
    BMC Infect Dis; 2016 Apr; 16():191. PubMed ID: 27138039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient.
    Cunha-Neto E; Coelho V; Guilherme L; Fiorelli A; Stolf N; Kalil J
    J Clin Invest; 1996 Oct; 98(8):1709-12. PubMed ID: 8878420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative Th17 and CD4
    Almeida MS; Lorena VMB; Medeiros CA; Junior WO; Cavalcanti MDGAM; Martins SM; de Morais CNL
    Scand J Immunol; 2018 Apr; 87(4):e12650. PubMed ID: 29473686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
    Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
    J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA; Rottenberg ME; de Titto EH
    Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens.
    Fuenmayor C; Higuchi ML; Carrasco H; Parada H; Gutierrez P; Aiello V; Palomino S
    Acta Cardiol; 2005 Feb; 60(1):33-7. PubMed ID: 15779849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection.
    Martins GA; Campanelli AP; Silva RB; Tadokoro CE; Russo M; Cunha FQ; Rizzo LV; Silva JS
    Microbes Infect; 2004 Nov; 6(13):1133-44. PubMed ID: 15488732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathology of cardiomyopathy in the experimental Chagas disease.
    Soares MB; Santos RR
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():257-62. PubMed ID: 10677729
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Puerta CJ; Cuellar A; Lasso P; Mateus J; Gonzalez JM
    Front Cell Infect Microbiol; 2022; 12():1075717. PubMed ID: 36683674
    [No Abstract]   [Full Text] [Related]  

  • 19. In Silico Guided Discovery of Novel Class I and II
    Acevedo GR; Juiz NA; Ziblat A; Pérez Perri L; Girard MC; Ossowski MS; Fernández M; Hernández Y; Chadi R; Wittig M; Franke A; Nielsen M; Gómez KA
    J Immunol; 2020 Mar; 204(6):1571-1581. PubMed ID: 32060134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.